[Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid].
D000577:Amides / Q000009:adverse effects / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D003864:Depression, Chemical; D004935:Esophageal Diseases / Q000139:chemically induced; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006505:Hepatitis / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology; D008105:Liver Cirrhosis, Biliary / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use*; D011516:Prothrombin / Q000032:analysis; D013276:Stomach Ulcer / Q000139:chemically induced; D008063:Thioctic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use*
D000577:Amides; D001798:Blood Proteins; D014815:Vitamins; D008063:Thioctic Acid; D011516:Prothrombin; D002784:Cholesterol; D011239:Prednisolone; D001663:Bilirubin
Die Therapie chronischer Lebererkrankungen mit Prednisolon und alpha-Liponsäure.